Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 1,478 | 3,000 | 0 | 1,804 | 0 |
| Gross Profit | 1,478 | 3,000 | N/A | 1,804 | N/A |
| Operating Expenses | 20,858 | 23,525 | 20,666 | 20,576 | -156,856 |
| Operating Income | -19,379 | -20,525 | -20,666 | -18,772 | 156,856 |
| Interest Expense | 235 | 743 | 86 | -792 | 4,112 |
| Other Income | 2,548 | 416 | 1,146 | -45 | 187 |
| Pre-tax Income | -17,067 | -20,852 | -19,606 | -18,025 | 152,931 |
| Income Tax | -196 | -201 | -199 | -1,440 | 8,821 |
| Net Income Continuous | -16,871 | -20,651 | -19,407 | -16,585 | 144,110 |
| Net Income | $-16,871 | $-20,651 | $-19,407 | $-16,585 | $144,110 |
| EPS Basic Total Ops | -0.51 | -0.65 | -0.63 | -0.53 | 4.70 |
| EPS Basic Continuous Ops | -0.51 | -0.65 | -0.63 | -0.54 | 4.70 |
| EPS Diluted Total Ops | -0.51 | -0.65 | -0.63 | -0.52 | 4.68 |
| EPS Diluted Continuous Ops | -0.51 | -0.65 | -0.63 | -0.53 | 4.68 |
| EBITDA(a) | $-19,379 | $-20,525 | $-20,666 | $-18,772 | $156,856 |